-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Rapid Therapeutic Science Laboratories, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2015 to Q1 2023.
- Rapid Therapeutic Science Laboratories, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$41.8K, a 94% increase year-over-year.
- Rapid Therapeutic Science Laboratories, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$1.15M, a 47.9% increase from 2021.
- Rapid Therapeutic Science Laboratories, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$2.21M, a 28.1% decline from 2020.
- Rapid Therapeutic Science Laboratories, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$1.72M.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)